Home›Search›Nowotwory

Nowotwory

Via Medica · Poland · Est. 1923

ISSN0029-540XeISSN2300-2115

SJR Q3✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q354

✓ Corroboration (2 more)+12

Total66

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 75% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.37

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.361

Aims & Scope

The Journal publishes original papers, review articles, case reports, letters to editor, book reviews, editorial comments and history notes covering all aspects of oncology but focusing on clinical studies, both research and treatment oriented with contributions from fields of epidemiology, tumor pathology, radiobiology and radiation physics.

General Information

Country / RegionPoland

Primary LanguageEnglish

1st Year Published1923

Frequencybimonthly

StatusActive

Total Publications—

Publisher OrgVia Medica

Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/12 · 67%

✅

Do you know the journal / publisher?

Via Medica

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0029-540X / 2300-2115

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

149

2021

129

2022

103

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ3

Cancer ResearchQ4

Subject Classification

Research Topics (OpenAlex)

Multiple and Secondary Primary CancersLanguage and CultureBreast Cancer Treatment StudiesAdvanced Radiotherapy TechniquesPolish Historical and Cultural StudiesIntellectual Property Rights and MediaCancer Diagnosis and TreatmentLung Cancer Treatments and MutationsGenetic factors in colorectal cancerCancer Treatment and Pharmacology

Frequently asked questions about Nowotwory

Is Nowotwory a predatory journal?

PubScope has no integrity flags on record for Nowotwory: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 66/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Nowotwory?

Nowotwory is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.37.

Is Nowotwory indexed in Scopus and Web of Science?

Nowotwory is indexed in Scopus, DOAJ.